LONG-TERM EFFICACY OF OMALIZUMAB IN PATIENTS WITH SEVERE ASTHMA

被引：0
|
作者：
Saji, J. [1 ]
Yamamoto, T. [1 ]
Arai, M. [2 ]
Mineshita, M. [3 ]
Miyazawa, T. [3 ]
机构：
[1] Kawasaki Municipal Tama Hosp, Dept Internal Med, Div Resp Dis, Kawasaki, Kanagawa, Japan
[2] Tsurukawa Mem Hosp, Tokyo, Japan
[3] St Marianna Univ, Sch Med, Dept Internal Med, Div Resp & Infect Dis, Miyazaki, Japan
来源：
RESPIROLOGY | 2014年 / 19卷
关键词：
D O I：
10.1111/resp.12417_2
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
O-A-019
引用
收藏
页码：7 / 7
页数：1
相关论文
共 50 条
  • [1] Assessment of Long-term Omalizumab Treatment in Patients with Severe Allergic Asthma Long-term Omalizumab Treatment in Severe Asthma
    Ozgur, Eylem Sercan
    Ozge, Cengiz
    Ilvan, Ahmet
    Nayci, Sibel Atis
    JOURNAL OF ASTHMA, 2013, 50 (06) : 687 - 694
  • [2] LONG -TERM SAFETY OF OMALIZUMAB IN PATIENTS WITH SEVERE ASTHMA
    Paixao, Maria
    Eusebio, Itziar
    Gomez Viciana, Maria
    Juarez, Cristina
    Diaz-Campos, Rocio
    Fernandez, Consuelo
    G-Moguel, Ismael
    Crespo, Jesus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB104 - AB104
  • [3] Long-term safety, efficacy, pharmacokinetics and pharmacodynamics of omalizumab in children with severe uncontrolled asthma
    Odajima, Hiroshi
    Ebisawa, Motohiro
    Nagakura, Toshikazu
    Fujisawa, Takao
    Akasawa, Akira
    Ito, Komei
    Doi, Satoru
    Yamaguchi, Koichi
    Katsunuma, Toshio
    Kurihara, Kazuyuki
    Teramoto, Takahide
    Sugai, Kazuko
    Nambu, Mitsuhiko
    Hoshioka, Akira
    Yoshihara, Shigemi
    Sato, Norio
    Seko, Noriko
    Nishima, Sankei
    ALLERGOLOGY INTERNATIONAL, 2017, 66 (01) : 106 - 115
  • [4] Omalizumab is effective in the long-term control of severe allergic asthma
    Lanier, BQ
    Corren, J
    Lumry, W
    Liu, J
    Fowler-Taylor, A
    Gupta, N
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2003, 91 (02) : 154 - 159
  • [5] Assesment of long-term omalizumab treatment in severe allergic asthma
    Ozgur, Eylem Sercan
    Ozge, Cengiz
    Ilvan, Ahmet
    Nayci, Sibel Atis
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [6] Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma
    Buhl, R
    Solèr, M
    Matz, J
    Townley, R
    O'Brien, J
    Noga, O
    Champain, K
    Fox, H
    Thirlwell, J
    Della Cioppa, G
    EUROPEAN RESPIRATORY JOURNAL, 2002, 20 (01) : 73 - 78
  • [7] Evaluation of long-term safety and efficacy of omalizumab in elderly patients with uncontrolled allergic asthma
    Tat, Tugba Songul
    Cilli, Aykut
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : 546 - 549
  • [8] Long-Term Safety and Efficacy of Mepolizumab in Patients with Severe Eosinophilic Asthma
    Albers, Frank C.
    Lugogo, Njira
    Gilson, Martyn J.
    Price, Robert
    Yancey, StevenW.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB14 - AB14
  • [9] Long-term efficacy of omalizumab (OMA) for patients with severe allergic asthma (SAA). Clinical assessment and relationship to serum IgE concentrations
    Kroegel, Claus
    Foerster, Martin
    Lerche, Kristin
    Aalamian-Mattheis, Maryam
    Happe, Janett
    Moeser, Anne
    Korn, Stephanie
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [10] Long-term efficacy and safety of omalizumab in patients with allergic asthma: A real-life study
    Papaioannou, Andriana, I
    Mplizou, Myrto
    Porpodis, Konstantinos
    Fouka, Evangelia
    Zervas, Eleftherios
    Samitas, Konstantinos
    Markatos, Miltiadis
    Bakakos, Petros
    Papiris, Spyridon
    Gaga, Mina
    Papakosta, Despoina
    Loukides, Stelios
    ALLERGY AND ASTHMA PROCEEDINGS, 2021, 42 (03) : 235 - 242
12345